May 14, 2018 / 5:25 PM / 3 months ago

BRIEF-ADMA Biologics Retires About 8.6 Million Shares Previously Issued to Biotest

May 14 (Reuters) - ADMA Biologics Inc:

* ADMA BIOLOGICS INC - RETIRES APPROXIMATELY 8.6 MILLION SHARES PREVIOUSLY ISSUED TO BIOTEST PHARMACEUTICALS CORPORATION AND ITS FORMER PARENT, BIOTEST AG

* ADMA BIOLOGICS - BPC WILL TRANSFER ABOUT 8.6 MILLION SHARES OF ADMA’S NON-VOTING COMMON STOCK BACK TO ADMA

* ADMA BIOLOGICS - RETIREMENT OF ABOUT 8.6 MILLION SHARES FOR WAIVER AND RELEASE OF CERTAIN ADMA RIGHTS UNDER AGREEMENT, DATED AS OF JANUARY 21, 2017

* ADMA BIOLOGICS INC - BPC WILL WAIVE AND TERMINATE ALL RIGHTS TO NAME A DIRECTOR AND OBSERVER TO ADMA’S BOARD OF DIRECTORS

* ADMA BIOLOGICS - ADMA WILL TERMINATE RIGHTS TO REPURCHASE 2 ADMA BIOCENTERS WHICH CO HAD PREVIOUSLY AGREED TO TRANSFER TO BPC ON JANUARY 1, 2019. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below